Results 181 to 190 of about 5,026 (198)

Comment on: “Emergent role of complement inhibitors in myasthenic crisis – Complement for crisis, FcRn for continuity”

Clinical Neurology and Neurosurgery
Haris Afridi, Kainat Afzal
openaire   +2 more sources

The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy

Advanced Drug Delivery Reviews, 2015
Jonathan T Sockolosky, Francis C Szoka
exaly  

FcRn: the neonatal Fc receptor comes of age

Nature Reviews Immunology, 2007
Derry C Roopenian, Shreeram Akilesh
exaly  

FcRn-Inhibitor Efgartigimod zur subkutanen Injektion zugelassen

InFo Neurologie + Psychiatrie
openaire   +1 more source

Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury

Proceedings of the National Academy of Sciences of the United States of America, 2017
Michal Pyzik, Sanda Win, Kristi Baker
exaly  

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting the Effects of Anti-FcRn Therapy on the Disposition of Endogenous IgG in Humans

Journal of Pharmaceutical Sciences, 2019
Joseph P Balthasar
exaly  

Repetitive nerve stimulation normalization after FcRn inhibitor therapy in refractory myasthenia gravis: A case report

Clinical Neurophysiology
Rajiv Wijesinghe, Richard Yitong Shao, Gaven Lin, Matthew Silsby   +3 more
openaire   +2 more sources

FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues

Biomolecules, 2018
Joseph P Balthasar
exaly  

Structure–activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction

Bioorganic and Medicinal Chemistry, 2008
exaly  

Efficacy and safety of the FCRN inhibitor, batoclimab, in graves' thyroidal and extrathyroidal disease: a proof-of-concept study

Endocrine Abstracts
George Kahaly, Jan Wolf, Anna-Lena Ganz, Maximillian Luffy, Katherine Albert, Maria Alba, E Lin, William Macias   +7 more
openaire   +1 more source